Alkermes plc (ALKS) Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Alkermes plc (NASDAQ: ALKS) FY 2026 M&A Release
19 articles, transcripts, and reports
Alkermes plc (NASDAQ: ALKS) FY 2026 M&A Release
Alkermes plc (NASDAQ: ALKS) Q4 2025 Earnings Conference
Alkermes plc (NASDAQ: ALKS) Q2 2025 Earnings Call dated Jul. 29, 2025 Corporate Participants: Sandy Coombs — Senior Vice President, Corporate Affairs and Investor Relations…
Alkermes plc (NASDAQ: ALKS) Q3 2025 Earnings Call dated Oct. 28, 2025 Corporate Participants: Sandra Coombs — Investor Relations Richard Pops — Chief Executive Officer…
Alkermes plc (NASDAQ: ALKS) Q2 2022 Earnings Conference
Alkermes plc (NASDAQ: ALKS) Q1 2022 Earnings Conference
Alkermes plc (NASDAQ: ALKS) Q3 2021 Earnings Conference
Alkermes plc (NASDAQ: ALKS) Q2 2021 Earnings Conference
Alkermes plc (NASDAQ: ALKS) Q1 2021 Earnings Conference